Home > Insider Trading > Filing (0001387131-19-000927)

Filing Details

Accession Number:: 0001387131-19-000927
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-06 17:47:12
Reporting Period:: 2019-02-05

Accepted Time:: 2019-02-06 17:47:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1422183	Fs Kkr Capital Corp	FSK	()	261630040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1438253	C. Michael Forman	C/O Fs Kkr Capital Corp. 201 Rouse Boulevard Philadelphia PA 19112	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-05	7,828	$6.36	160,543	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2019-02-06	7,845	$6.35	168,388	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	197,998	Indirect	By MCFDA SCV LLC
Common Stock	924,609	Indirect	By FSH Seed Capital Vehicle I LLC
Common Stock	14,454	Indirect	By Spouse
Common Stock	3,633	Indirect	By Trust FBO Minor Children
Common Stock	12,824	Indirect	In 401(k) account
Common Stock	8,783	Indirect	In IRA account

Footnotes

The purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by The 2011 Forman Investment Trust. The purchases were effected in multiple transactions at prices ranging from $6.33 to $6.39, inclusive. The price reported in Column 4 is the weighted average price. The reporting person undertakes to provide, upon request, full information regarding the number of shares purchased in each transaction. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by The 2011 Forman Investment Trust. The purchases were effected in multiple transactions at prices ranging from $6.295 to $6.39, inclusive. The price reported in Column 4 is the weighted average price. The reporting person undertakes to provide, upon request, full information regarding the number of shares purchased in each transaction. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Includes shares received through stock distributions and shares received on account of reinvested distributions.
MCFDA SCV LLC is a wholly-owned special purpose financing vehicle of which The 2011 Forman Investment Trust is a member and the reporting person is the manager. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust and MCFDA SCV LLC that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
FSH Seed Capital Vehicle I LLC is a wholly-owned special purpose financing subsidiary of Franklin Square Holdings, L.P. The reporting person disclaims beneficial ownership of any shares held by Franklin Square Holdings, L.P. and FSH Seed Capital Vehicle I LLC that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.